However, a study conducted in 872 Asian patients with leprosy treated with dapsone found that the presence of the HLA-B*13:01 allele was useful as a risk predictor for dapsone hypersensitivity syndrome (with a sensitivity of 85.5% and specificity of 85.7%) [67]. This evidence concerns the gene HLA-B and leprosy.